Biosimilars Market

R&D

Eloise McLennan interview with Peter Stenico

Reuters Pharma Europe 2024 – Peter Stenico

Pioneering access to biosimilars is crucial for strengthening health equity by providing affordable, life-changing therapies to patients worldwide.

Partner Content

World Biosimilars Market will surge at 27%+ CAGR up to 2025

Biosimilars Market will surpass USD 69 billion by 2025

News

AbbVie turbocharges its US investment promise to $100bn

AbbVie finally agrees a most-favoured nation pricing deal with the US administration, with a $100 billion investment promise attached.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Editor's Picks